Adalvo
Exhibitor
Information
Adalvo is a leading B2B pharmaceutical company in Europe with over 110 global partners in 100+ countries. The company's goal is to improve patient care by providing high-quality products and services through a smart collaboration network. Adalvo's unique approach is tailored to each partner, helping them grow their business and achieve their objectives, whether that's increasing revenue or expanding into new markets. The company also prioritizes employee development and community growth while striving for excellence. Adalvo's commitment to excellence and making a difference ensures that it remains a key player in the competitive pharmaceutical industry.
Organization Type
Other
Country
Malta
Zone
Finished Dosage Formulations
Business Activity
Out-licensing specialist
Markets Active In
North America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)
Products and Services
Biopharmaceutical ProductsFinished Dosage FormsAPIs (Active Pharmaceutical Ingredients)
Finished Formulation products Distributor/Buyer, Nutraceuticals, OTC, Contract Formulator
AntibioticsPeptidesGeneric Antibiotics
Offering: Biopharmaceutical Products
BiosimilarsTech transfer and Scale up
Offering: Finished Dosage Forms
InjectablesOut-licensing